Ghost Tree Capital, LLC historic quarter change: Foreign ADRs, New
In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 14 quarters from 2013-12-31 to 2024-09-30, Ghost Tree Capital, LLC opened 14 positions, added to 6, reduced 8 and sold out of 13.
- Q2 2024: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 0.
- Q3 2016: Stock DBV TECHNOLOGIES S A; Country of operation —; Class SPONSORED ADR; Shares before 0.
- Q2 2016: Stock FLAMEL TECHNOLOGIES SA; Country of operation —; Class SPONSORED ADR; Shares before 0.
- Q2 2016: Stock ASCENDIS PHARMA A S; Country of operation —; Class SPONSORED ADR; Shares before 0.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1595851), 14 quarters: Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-17); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-09-09); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2013-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2024 | ASCENDIS PHARMA A/S CUSIP 04351P101 | SPONSORED ADR | 0 | 86,721 | +86,721 | $0 | $11,827,010 | +$11,827,010 | 2024-08-14 | |
| Q3 2016 | DBV TECHNOLOGIES S A CUSIP 23306J101 | SPONSORED ADR | 0 | 250,000 | +250,000 | $0 | $9,083,000 | +$9,083,000 | 2016-11-14 | |
| Q2 2016 | FLAMEL TECHNOLOGIES SA CUSIP 338488109 | SPONSORED ADR | 0 | 350,000 | +350,000 | $0 | $3,759,000 | +$3,759,000 | 2016-08-12 | |
| Q2 2016 | ASCENDIS PHARMA A S CUSIP 04351P101 | SPONSORED ADR | 0 | 100,000 | +100,000 | $0 | $1,327,000 | +$1,327,000 | 2016-08-12 | |
| Q4 2015 | DBV TECHNOLOGIES S A CUSIP 23306J101 | SPONSORED ADR | 0 | 80,000 | +80,000 | $0 | $5,314,000 | +$5,314,000 | 2016-02-17 | |
| Q4 2015 | AKARI THERAPEUTICS PLC CUSIP 00972G108 | SPONSORED ADR | 0 | 47,116 | +47,116 | $0 | $683,000 | +$683,000 | 2016-02-17 | |
| Q3 2015 | ASCENDIS PHARMA A/S - ADR CUSIP 04351P101 | ADR | 0 | 97,135 | +97,135 | $0 | $1,719,000 | +$1,719,000 | 2015-11-16 | |
| Q2 2015 | ASCENDIS PHARMA A S CUSIP 04351P101 | SPONDSORED ADR | 0 | 63,739 | +63,739 | $0 | $1,127,000 | +$1,127,000 | 2015-09-09 | |
| Q1 2015 | GW PHARMACEUTICALS PLC CUSIP 36197T103 | ADS | 0 | 45,000 | +45,000 | $0 | $4,101,000 | +$4,101,000 | 2015-05-15 | |
| Q4 2014 | FLAMEL TECHNOLOGIES SA CUSIP 338488109 | SPONSORED ADR | 0 | 325,000 | +325,000 | $0 | $5,567,000 | +$5,567,000 | 2015-02-18 | |
| Q4 2014 | DBV TECHNOLOGIES S A CUSIP 23306J101 | SPONSORED ADR | 0 | 80,000 | +80,000 | $0 | $2,170,000 | +$2,170,000 | 2015-02-18 | |
| Q3 2014 | AMARIN CORP PLC CUSIP 023111206 | SPONS ADR NEW | 0 | 200,000 | +200,000 | $0 | $218,000 | +$218,000 | 2014-11-14 | |
| Q1 2014 | GW PHARMACEUTICALS PLC CUSIP 36197T103 | ADS | 0 | 25,000 | +25,000 | $0 | $1,484,000 | +$1,484,000 | 2014-05-15 | |
| Q1 2014 | AMARIN CORP PLC CUSIP 023111206 | SPONS ADR NEW | 0 | 300,000 | +300,000 | $0 | $543,000 | +$543,000 | 2014-05-15 |
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||